Janux Therapeutics, Inc.
NASDAQ:JANX
54.21 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -58.293 | -63.059 | -32.672 | -6.784 | -4.004 |
| Depreciation & Amortization
| 1.955 | 0.841 | 0.113 | 0.013 | 0.006 |
| Deferred Income Tax
| -0.277 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 20.005 | 17.203 | 6.91 | 0.072 | 0.006 |
| Change In Working Capital
| -6.554 | 4.276 | 8.842 | 0.389 | -0.069 |
| Accounts Receivables
| 0 | 0 | 8 | -8 | 0 |
| Inventory
| 0 | 0 | 0.831 | 0.375 | 0 |
| Accounts Payables
| 0.277 | -0.294 | 2.139 | 0.014 | 0.004 |
| Other Working Capital
| -6.831 | 4.57 | -2.128 | 8 | -0.073 |
| Other Non Cash Items
| -7.411 | -2.183 | -0.169 | 1.941 | 0.233 |
| Operating Cash Flow
| -50.575 | -42.922 | -16.976 | -4.369 | -3.828 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -1.85 | -6.445 | -1.482 | 0 | 0 |
| Acquisitions Net
| 39.344 | -64.711 | 339.481 | 0 | 0 |
| Purchases Of Investments
| -317.344 | -294.389 | -473.626 | 0 | 0 |
| Sales Maturities Of Investments
| 278 | 359.1 | 134.145 | 0 | 0 |
| Other Investing Activites
| -39.344 | 64.711 | -339.481 | 0 | 0 |
| Investing Cash Flow
| -41.194 | 58.266 | -340.963 | 0 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | -2.5 | -4 |
| Common Stock Issued
| 56.53 | 0.5 | 204.167 | 9.024 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 3.018 | 0.5 | 182.357 | 5 | 4 |
| Financing Cash Flow
| 59.548 | 0.5 | 386.524 | 11.524 | 4 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -32.221 | 15.844 | 28.585 | 7.155 | 0.172 |
| Cash At End Of Period
| 20.021 | 52.242 | 36.398 | 7.813 | 0.658 |